Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Assoian RK, Boardman LA, Drosinos S . (1989). A preparative suspension culture system permitting quantitation of anchorage-independent growth by direct radiolabeling of cellular DNA. Anal Biochem 177: 95–99.
Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J et al. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84–89.
Bracke ME, Van Roy FM, Mareel MM . (1996). The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 213: 123–161.
Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG et al. (2000). The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76–83.
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH . (2007). Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: 1979–1987.
Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. (2001). The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267–1278.
de Larco JE, Todaro GJ . (1978). Growth factors from murine sarcoma virus-transformed cells. J Cell Physiol 94: 335–342.
Docherty NG, O'Sullivan OE, Healy DA, Murphy M, O'neill AJ, Fitzpatrick JM et al. (2006). TGF-betal-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 290: F1202–F1212.
Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M. . (2004). PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193–204.
Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S, Yuspa SH . (1994). Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev 8: 2429–2440.
Gold LI . (1999). The role for transforming growth factor-beta (TGF-beta) in human cancer. Cri Rev Oncog 10: 303–360.
Jong SM, Wang L-H . (1987). The transforming protein P68gag-ros of avian sarcoma virus UR2 is a transmembrane protein with the gag portion protruding extracellularly. Oncogene Res 1: 7–21.
Kizaka-Kondoh S, Akiyama N, Okayama H . (2000). Role of TGF-beta in EGF-induced transformation of NRK cells is sustaining high-level EGF-signaling. FEES Lett 466: 160–164.
Massagué J, Blain SW, Lo RS . (2000). TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295–309.
Nguyen KT, Wang WJ, Chan JL, Wang LH . (2000). Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells. Oncogene 19: 5385–5397.
Sachdev P, Zeng L, Wang L-H . (2002). Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes. J Biol Chem 277: 17638–17648.
Saha D, Datta PK, Sheng H, Morrow JD, Wada M, Moses HL et al. (1999). Synergistic induction of cyclooxygenase-2 by transforming growth factor-betal and epidermal growth factor inhibits apoptosis in epithelial cells. Neoplasia 1: 508–517.
Seton-Rogers SE, Lu Y, Hines LM, Koundinya M, LaBaer J, Muthuswamy SK et al. (2004). Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci USA 101: 1257–1262.
Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J . (2003). Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci USA 100: 8430–8435.
Stolz DB, Michalopoulos GK . (1997). Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro. J Cell Physiol 170: 57–68.
Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR et al. (1998). Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 4: 802–807.
Thiery JP . (2003). Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740–746.
Uttamsingh S, Zong CS, Wang L-H . (2003). Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 Is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts. J Biol Chem 278: 18798–18810.
Wang LH . (2004). Molecular signaling regulating anchorage-independent growth of cancer cells. Mt Sinai J Med 71: 361–367.
Welch DR, Fabra A, Nakajima M . (1990). Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87: 7678–7682.